1/29
Looks like no tags are added yet.
Name | Mastery | Learn | Test | Matching | Spaced |
---|
No study sessions yet.
What antivirals are used for Hepatitis B?
Lamivudine, Adefovir, Entecavir, Alpha interferon 2A/B
What is the MOA for Lamivudine
Inhibits HBV reverse transcription
What are the ADRS of Lamivudine
Minimal ADRs
What is the MOA for Adefovir
Inhibits HBV reverse transcriptase
What are the ADRs associated with Adefovir?
Proteinuria, increase SCr
What is the MOA for Entecavir
potent selective inhibitor of HBV polymerase
What are the ADRS of Entecavir?
HA, fatigue, muscle pain
What is the MOA for Alpha- Interferon 2a/2b
inhibits RNA transcription
What is the ADRs for Alpha interferon?
Vision changes, palpations, breathing problems
What medications should not be used for Hep B?
Truvada (tenofovir disoproxil fumarate and emtricitabine)
Emtriva (emtricitabine)
Viread (tenofovir disoproxil fumarate)
Note: These are used for HIV prevention
What antivirals are used for Hep C?
Glecaprevir/Pibrentasvir → Mavyret
Sofosbuvir/Velpatasvir → Epclusa
Ledipasvir/Sofosbuvir → Harvoni
Ribavirin → Copegus
Sofosbuvir/Velpatasvir/Voxilaprevir → Vosevi
What are the categories of Hep C treatments?
Someone who has not received Hep C treatment before
Failed previous therapy with PEG-IFN (Pegylated Interferon) plus RBV (Ribavirin)
Patients who have failed previous therapy with Sofosbuvir or Elbasvir/Grazoprevir
What is there to know about treating someone who has not received Hep C treatment before?
There is a preferred and alternative pathway:
Preferred is organized into two subgroups based on genotype of Hep C virus
Group 1: Genotypes 1a, 1b, 2, 4;
Group 2: Genotype 3
Alternative is organized into subgroups based on race, whether patient is HIV+ or HCV RNA is greater than 6 million copies, and genotype
Group 1: Genotype 1a or 1b (non-Black, HIV-negative, HCV RNA < 6 mil copies/mL)
Genotype 1a or 1b (Black, HIV-positive, or HCV RNA > 6 mil copies/mL) → Ledipasvir 90 mg / Sofosbuvir 400 mg
Genotypes 4, 5, 6
preferred treatment for Hep C patient who is treatment naive
Alternative treatment for Hep C patients who are treatment naive
What is there to know about treating someone who failed previous therapy with PEG-IFN + RBV?
There is a preferred and alternative pathway
Preferred is organized into groups based on Genotype
Group 1: 1a, 1b, 2, 4, 5, 6
Group 2: 3
Alternative is organized as well based on genotype
Group 1: 1a, 1b
group 2: 4, 5, 6
What is the preferred treatment for someone who failed previous therapy with PEG-IFN + RBV?
What is the alternative treatment who failed previous therapy with PEG-IFN + RBV?
What is there to know about treating someone with Hep C who had previous therapy with Sofosbuvir or Elbasvir/Grazoprevir?
Organized based on genotype
Group 1: 1a, 1b, 2, 4, 5, 6
group 2: genotype 3
How to treat someone with HEP C who had previous therapy with Sofosbuvir or Elbasvir/Grazoprevir?
Brand name of Glecaprevir/pibrentasvir
Mavyre
ADRs for Glecaprevir/pibrentasvir
Headache and fatigue
Brand name of Sofosbuvir/velpatasvir
Epclusa
ADRs for Sofosbuvir/velpatasvir
by itself→ headache and fatigue
when taken with ribavirin in patients with decompensated cirrhosis—> it causes the above symptoms + anemia, nausea, insomnia, and diarrhea
Brand name for Ledipasvir/sofosbuvir
Harvoni
ADRS of Ledipasvir/sofosbuvir
Asthenia, headache, and fatigue
Brand name of Ribavirin
Copegus
ADRs of Ribavirin
Fatigue/asthenia, pyrexia, myalgia, and headache in adults receiving combination therapy
Brand name of Sofosbuvir/velpatasvir/voxilaprevir
Vosevi
ADRs of Sofosbuvir/velpatasvir/voxilaprevir
Headache, fatigue, diarrhea, and nausea